Outset Medical, Inc. (OM)
Outset Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in San Jose, CA, US. The stock last traded at $4.67, down 3.11% on the session, giving a market capitalisation of $86.6M. On trailing twelve-month figures it carries a trailing P/E of -1.14, a net margin of -63.1%. Its beta of 1.92 implies it has historically moved more than the broad market.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Outset Medical, Inc. is most often compared with the following Healthcare names: